Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alkermes plc stock logo
ALKS
Alkermes
$28.81
-0.1%
$29.94
$22.90
$36.45
$4.75B0.471.73 million shs2.94 million shs
Cigna Group stock logo
CI
Cigna Group
$326.68
-1.0%
$320.71
$262.03
$370.83
$87.27B0.441.72 million shs3.40 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$310.69
+1.3%
$300.65
$250.05
$459.77
$8.93B1.47372,945 shs677,983 shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$308.85
+2.1%
$339.15
$248.88
$630.73
$280.17B0.447.44 million shs13.58 million shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alkermes plc stock logo
ALKS
Alkermes
-0.24%-1.70%-3.58%-13.19%+17.34%
Cigna Group stock logo
CI
Cigna Group
+4.17%+4.56%+4.25%+1.13%-2.65%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
-1.39%+1.36%+2.75%-1.78%-24.31%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
+0.08%-1.46%+2.52%-41.33%-37.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alkermes plc stock logo
ALKS
Alkermes
4.906 of 5 stars
4.43.00.04.22.92.51.9
Cigna Group stock logo
CI
Cigna Group
4.9765 of 5 stars
3.53.03.34.22.11.73.8
Medpace Holdings, Inc. stock logo
MEDP
Medpace
4.7894 of 5 stars
3.12.00.04.62.74.22.5
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4.9978 of 5 stars
4.33.04.24.02.93.32.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alkermes plc stock logo
ALKS
Alkermes
2.83
Moderate Buy$40.0038.84% Upside
Cigna Group stock logo
CI
Cigna Group
3.00
Buy$380.3916.44% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.21
Hold$344.8210.98% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.60
Moderate Buy$415.5734.55% Upside

Current Analyst Ratings Breakdown

Latest UNH, ALKS, MEDP, and CI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Cigna Group stock logo
CI
Cigna Group
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$371.00
6/25/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$400.00 ➝ $385.00
6/24/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform ➝ Equal Weight$300.00
6/23/2025
Cigna Group stock logo
CI
Cigna Group
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/20/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$405.00 ➝ $418.00
6/17/2025
Alkermes plc stock logo
ALKS
Alkermes
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$33.00 ➝ $42.00
6/11/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
6/11/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$312.00
6/6/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
6/3/2025
Cigna Group stock logo
CI
Cigna Group
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$371.00
6/3/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$552.00 ➝ $353.00
(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alkermes plc stock logo
ALKS
Alkermes
$1.56B3.05$2.64 per share10.90$9.05 per share3.18
Cigna Group stock logo
CI
Cigna Group
$247.12B0.35$39.08 per share8.36$148.27 per share2.20
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.11B4.23$13.93 per share22.30$26.56 per share11.70
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$400.28B0.70$33.10 per share9.33$106.78 per share2.89
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alkermes plc stock logo
ALKS
Alkermes
$367.07M$2.0913.7821.031.8023.30%27.52%17.98%7/23/2025 (Estimated)
Cigna Group stock logo
CI
Cigna Group
$3.43B$18.0618.099.890.941.97%18.63%4.97%7/31/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.1023.7222.745.6119.31%54.36%20.81%7/21/2025 (Confirmed)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$14.41B$23.8812.939.301.435.39%26.29%8.67%7/15/2025 (Estimated)

Latest UNH, ALKS, MEDP, and CI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Alkermes plc stock logo
ALKS
Alkermes
$0.42N/AN/AN/A$343.20 millionN/A
7/21/2025Q2 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.01N/AN/AN/A$537.70 millionN/A
5/2/2025Q1 2025
Cigna Group stock logo
CI
Cigna Group
$6.35$6.74+$0.39$4.85$60.39 billion$65.45 billion
5/1/2025Q1 2025
Alkermes plc stock logo
ALKS
Alkermes
$0.32$0.13-$0.19$0.13$307.53 million$306.51 million
4/21/2025Q1 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.06$3.67+$0.61$3.67$528.38 million$558.57 million
4/17/2025Q1 2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$7.29$7.20-$0.09$6.85$111.56 billion$109.58 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alkermes plc stock logo
ALKS
Alkermes
N/AN/AN/AN/AN/A
Cigna Group stock logo
CI
Cigna Group
$6.041.85%N/A33.44%5 Years
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$8.842.86%N/A37.02%15 Years

Latest UNH, ALKS, MEDP, and CI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/5/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.213%6/16/20256/16/20256/24/2025
4/23/2025
Cigna Group stock logo
CI
Cigna Group
quarterly$1.511.79%6/3/20256/3/20256/18/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alkermes plc stock logo
ALKS
Alkermes
N/A
3.33
2.92
Cigna Group stock logo
CI
Cigna Group
0.65
0.72
0.72
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.71
0.85
0.85

Institutional Ownership

CompanyInstitutional Ownership
Alkermes plc stock logo
ALKS
Alkermes
95.21%
Cigna Group stock logo
CI
Cigna Group
86.99%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
Alkermes plc stock logo
ALKS
Alkermes
4.40%
Cigna Group stock logo
CI
Cigna Group
0.70%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alkermes plc stock logo
ALKS
Alkermes
1,800164.90 million157.65 millionOptionable
Cigna Group stock logo
CI
Cigna Group
73,500267.14 million265.27 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,90028.74 million22.91 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
400,000907.14 million904.60 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alkermes stock logo

Alkermes NASDAQ:ALKS

$28.81 -0.02 (-0.07%)
Closing price 04:00 PM Eastern
Extended Trading
$28.80 0.00 (-0.02%)
As of 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Cigna Group stock logo

Cigna Group NYSE:CI

$326.68 -3.32 (-1.01%)
Closing price 03:59 PM Eastern
Extended Trading
$326.00 -0.68 (-0.21%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Medpace stock logo

Medpace NASDAQ:MEDP

$310.69 +3.89 (+1.27%)
Closing price 04:00 PM Eastern
Extended Trading
$309.77 -0.92 (-0.29%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

UnitedHealth Group stock logo

UnitedHealth Group NYSE:UNH

$308.85 +6.23 (+2.06%)
Closing price 03:59 PM Eastern
Extended Trading
$307.38 -1.47 (-0.48%)
As of 06:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.